孟鲁司特钠联合阿奇霉素与布地奈德治疗儿童支原体肺炎的效果观察

Clinical observation of montelukast sodium combined with azithromycin and budesonide in the treatment of mycoplasma pneumonia in children

目的 探究孟鲁司特钠联合阿奇霉素与布地奈德治疗儿童支原体肺炎的效果.方法 选取支原体肺炎患儿134例为研究对象,随机分为对照组和观察组,各67例.对照组使用阿奇霉素与布地奈德进行治疗,观察组在对照组基础上联合孟鲁司特钠进行治疗.比较两组治疗效果及临床症状消失时间和住院时间.结果 观察组总有效率比对照组高（P〈0.05）;观察组患者喘息消失时间、咳嗽消失时间、肺部体征、住院时间均比对照组短（P〈0.05）.结论 孟鲁司特钠联合阿奇霉素与布地奈德治疗能有效缩短支原体肺炎患儿住院时间,提高治疗效果.

Objective To investigate the effect of montelukast sodium combined with azithromycin and budesonide in the treatment of mycoplasma pneumonia in children. Methods One hundres and thirty-four cases of children with mycoplasma were selected and randomly divided into control group and observation, with 67 cases in each group. The control group was treated with azithromycin and budesonide, while the observation group was treated with montelukast sodium on the basis of the control group. The therapeutic effect, clinical symptom disappearance time and hospital stay were compared between the two groups. Results The total effect of the observation group was higher than that of the control group （P〈0.05）; the wheezing disappearance time, cough disappearance time, pulmonary symptoms and hospitalization time of the observation group were shorter than those of the control group （P〈0.05）. Conclusion Montelukast sodium combined with azithromycin and budesonide can effectively shorten the duration of hospitalization and improve the treatment effect.